About

DeltaSinc is an innovative technology company in the digital health sector, transforming advanced research into practical, commercially viable solutions. By combining artificial intelligence, smart sensors, and computer vision, it develops technologies that integrate scientific rigor with a modern user experience, actively contributing to the advancement of personalized medicine. DeltaSinc is a spin-off company of Aristotle University of Thessaloniki and aims at exploiting particular research outcomes generated from research and innovation projects.

Solution & Product

At the core of its operations is GutLogix, an innovative platform that radically simplifies endoscopy workflows, reducing administrative burden and accelerating diagnosis. GutLogix eliminates endoscopy "bureaucracy", delivering faster diagnoses and better outcomes combining AI and web technologies.

Innovation & Scalability

DeltaSinc’s innovation is an all‑in‑one ecosystem that connects and empowers every stakeholder in the endoscopy unit through a single, seamless platform. Scalability depends on optimizing resource needs and navigating regulatory requirements. Starting in selected markets where we have active partnerships, we will validate our value proposition before scaling gradually to a broader market presence.

Traction & achievements

DeltaSinc emerged from the successful completion of an EU-funded project (HosmartAI), in which the core technology was developed and validated through a pilot clinical study. After the project, the technology was further evolved in close collaboration with end users, resulting in a set of MVPs.

Team & Why Us

The team comprises academics, researchers, and engineers in biomedical engineering, with proven experience in addressing complex problems.

Funding Needs

The company is currently self-funded by its co-founders and is continuously seeking grants and partnerships to advance the readiness level of its technologies.